> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# AI Can Cut Drug Development Costs, Time: Experts
- URL: https://www.fdaweb.com/ai-can-cut-drug-development-costs-time-experts/
- Published: 2025-09-03T12:00:00.000Z
- Updated: 2026-09-14T15:20:44.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5159807

Drug developers are using artificial intelligence (AI) technologies for discovery and safety testing to get faster and cheaper results and help reduce the dependence on animal testing. That’s the view of several experts interviewed by Reuters for a [story](https://www.reuters.com/business/healthcare-pharmaceuticals/ai-driven-drug-discovery-picks-up-fda-pushes-reduce-animal-testing-2025-09-02/?ref=fdaweb.com) on AI-driven drug development.

“Within the next three to five years,” the post says, “using AI and cutting back on animal testing could reduce timelines and costs by at least half….”

Reuters says the change aligns with FDA’s vision of approaches such as AI-driven technologies, human cell models, and computational models becoming the new standard as the agency plans to make animal studies the exception for pre-clinical safety and toxicity testing in three to five years.